Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015

PLoS One. 2015 Jul 2;10(7):e0130697. doi: 10.1371/journal.pone.0130697. eCollection 2015.

Abstract

Timely and accurate measurement of population protection against measles is critical for decision-making and prevention of outbreaks. However, little is known about how survey-based estimates of immunization (crude coverage) compare to the seroprevalence of antibodies (effective coverage), particularly in low-resource settings. In poor areas of Mexico and Nicaragua, we used household surveys to gather information on measles immunization from child health cards and caregiver recall. We also collected dried blood spots (DBS) from children aged 12 to 23 months to compare crude and effective coverage of measles immunization. We used survey-weighted logistic regression to identify individual, maternal, household, community, and health facility characteristics that predict gaps between crude coverage and effective coverage. We found that crude coverage was significantly higher than effective coverage (83% versus 68% in Mexico; 85% versus 50% in Nicaragua). A large proportion of children (19% in Mexico; 43% in Nicaragua) had health card documentation of measles immunization but lacked antibodies. These discrepancies varied from 0% to 100% across municipalities in each country. In multivariate analyses, card-positive children in Mexico were more likely to lack antibodies if they resided in urban areas or the jurisdiction of De Los Llanos. In contrast, card-positive children in Nicaragua were more likely to lack antibodies if they resided in rural areas or the North Atlantic region, had low weight-for-age, or attended health facilities with a greater number of refrigerators. Findings highlight that reliance on child health cards to measure population protection against measles is unwise. We call for the evaluation of immunization programs using serological methods, especially in poor areas where the cold chain is likely to be compromised. Identification of within-country variation in effective coverage of measles immunization will allow researchers and public health professionals to address challenges in current immunization programs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Child, Preschool
  • Developing Countries
  • Dried Blood Spot Testing
  • Drug Stability
  • Drug Storage
  • Female
  • Health Care Surveys / statistics & numerical data
  • Health Records, Personal
  • Humans
  • Immunization Programs / economics
  • Immunization Programs / statistics & numerical data*
  • Infant
  • Male
  • Measles / blood
  • Measles / immunology
  • Measles / prevention & control*
  • Measles / virology
  • Measles Vaccine / administration & dosage*
  • Measles Vaccine / economics
  • Measles Vaccine / supply & distribution
  • Measles virus / immunology
  • Measles virus / isolation & purification
  • Mexico
  • Middle Aged
  • Nicaragua
  • Vaccination / instrumentation
  • Vaccination / statistics & numerical data*

Substances

  • Antibodies, Viral
  • Measles Vaccine

Grants and funding

Funding for this study came from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), the Spanish Agency for International Development Cooperation (http://www.aecid.es/EN/aecid), and the Carlos Slim Health Institute (http://www.salud.carlosslim.org/english/). Funds were managed and disbursed by the Inter-American Development Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.